Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Player Avatar TradeWiz101 (< 20) Submitted: 1/29/2013 9:11:33 AM : Outperform Start Price: $0.00 KERX Score: 0

Here we'll go!

Featured Broker Partners


Advertisement